Seeing Is Believing
with an average price target of $15.51. This is a potential upside of $7.84 (102.22%) from yesterday's end of day stock price of $7.67.
Lyra Therapeutics 's activity chart (see below) currently has 0 price targets and 1 ratings on display.
Analysts average stock forecasts to be materialized ratio is 78.57% with an average time for these price targets to be met of 575.17 days.
Highest price target for LYRA is $16, Lowest price target is $16, average price target is $16.
Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 26-May-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$16
$9.53 (147.30%)
$16
1 months 26 days ago
(14-Aug-2025)
5/7 (71.43%)
$8.9 (125.35%)
422
Buy
1 years 1 months 25 days ago
(15-Aug-2024)
1/1 (100%)
$9 (150.00%)
1105
Hold
$0.5
$-5.97 (-92.27%)
1 years 5 months 3 days ago
(07-May-2024)
1/1 (100%)
$0.08 (19.05%)
386
Hold
$15
1 years 5 months 4 days ago
(06-May-2024)
1/1 (100%)
$11.36 (312.09%)
605
Buy
$10
$3.53 (54.56%)
$11
1 years 5 months 8 days ago
(02-May-2024)
6/6 (100%)
$5.37 (115.98%)
933
What is LYRA (Lyra Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?
Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?
Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?